Bruna Velosa Ferreira/LinkedIn
Jun 17, 2026, 14:54
Bruna Velosa Ferreira: PV and ET – Beyond Blood Count Control
Bruna Velosa Ferreira, Hematologist at the Champalimaud Clinical Center, shared a post on LinkedIn:
“PV and ET: Beyond Blood Count Control
Three themes that repeatedly emerged across the MPN sessions at EHA2026:
- Disease modification in PV and ET.
- Markers of biological disease activity beyond conventional risk stratification.
- Emerging therapeutic approaches targeting different aspects of MPN biology, including iron metabolism and mutant CALR.
These are exciting developments for the field, and it will be fascinating to follow how these concepts evolve in the coming years.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments